MENU
BCRX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
BioCryst Pharmaceuticals (BCRX) Ownership - Who owns BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
4505 Emperor Boulevard
Phone
+1 919 859-1302
Employees
536
Web
https://www.biocryst.com
Details
Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
1.63B
P/E Ratio
N/A
Total Cash
320.85M
Projected Growth
N/A
Total Debt
808.74M
Revenue
450.71M
Risk (Beta)
0.95
Dividend Yield
N/A
Total Cash/Share
1.54
Total Debt/Equity
N/A
Revenue/Share
2.18 USD as % of share price
Fundamentals
BCRX
Capitalization
1.63B
P/E Ratio
N/A
Risk (Beta)
0.95
Dividend Yield
N/A
Total Cash
321M
Total Cash/Share
1.54
Total Debt
809M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
2.18%
Revenue
451M
ROE
N/A
Book Value
-475.93M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-0.43
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2.09M
Current Ratio
2.63
Current Revenue Per Employee
226782.77
Dividends Per Share - Security
N/A
EBITDA
12.8M
Float
N/A
Float - Current
N/A
Gross Income Margin
95.34
Revenue To Assets
-17.65
Shares Held By Institutions
1.81B
Shares Outstanding - Current
209M
Total Liabilities
966M
Total Volume MTD
N/A
Value
1
Gain YTD
5.851
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of small molecule pharmaceuticals
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
4505 Emperor Boulevard
Phone
+1 919 859-1302
Employees
536
Web
https://www.biocryst.com